Bicara Therapeutics is focused on developing innovative targeted therapies for cancer treatment, specifically through the use of dual-action antibodies that modulate the tumor microenvironment
Bicara Therapeutics is focused on developing innovative targeted therapies for cancer treatment, specifically through the use of dual-action antibodies that modulate the tumor microenvironment.